Effects of propofol on endothelial cells subjected to a peroxynitrite donor (SIN-1)

Authors: Mathy-Hartert, M.1; Mouithys-Mickalad, A.1; Kohnen, S.; Deby-Dupont, G.2; Lamy, M.3; Hans, P.3

Source: Anaesthesia, Volume 55, Number 11, November 2000 , pp. 1066-1071(6)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Abstract:

We investigated the effect of propofol on endothelial cells subjected to the peroxynitrite (ONOO) donor 3-morpholino sydnonimine (SIN-1). Cells were incubated overnight with 0.5, 1.0 or 2.0 mmSIN-1, with or without 10−3 mpropofol (Diprivan®). Cytotoxicity, assessed by measuring the release of pre-incorporated 51Cr, increased when the concentration of SIN-1 increased, and was significantly decreased by 10−3 mpropofol (90%, 78% and 28% of protection against 0.5, 1.0 and 2.0 mmSIN-1, respectively). Cell protection against 1 mmSIN-1 was tested with 0.03-1.0 mmpropofol and this was compared to tyrosine, a target molecule for peroxynitrite. Propofol protected cells in a dose-dependent manner (r = 0.98; p < 0.001) and was as effective as tyrosine. Finally, using high-performance liquid chromatography, we demonstrated that propofol reacted with ONOO more rapidly than did tyrosine, inhibiting nitrotyrosine formation. In the absence of propofol, 3.5 mmONOO with 1 mmtyrosine yielded 39.6% nitrotyrosine, but nitrotyrosine was not produced when 5 mmpropofol was added. We conclude that propofol protects endothelial cells against the toxicity of ONOO. The anti-oxidant properties of propofol can be partially attributed to its scavenging effect on peroxynitrite, a property that might be relevant in pathological situations involving a significant contribution of peroxynitrite to tissue damage.

Keywords: Anaesthetics; intravenous; propofol

Document Type: Research article

Affiliations: 1: Research Fellow, Centre for Oxygen Research & Development, 2: Fellow, Laboratory of Homogenous Catalysis (CERM), Institutde Chimie, B6a, Research Associate and 3: Professor, Department of Anaesthesia and Intensive Care Medicine, University Hospital, B35, Domaine Universitaire du Sart Tilman, 4000 Liège, Belgium

Publication date: 2000-11-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page